CJS Securities upgraded Ingevity to Outperform from Market Perform with a $58 price target. The analyst cites a strong carbon outlook and the termination of crude tall oil contracts for the upgrade.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NGVT:
- Ingevity price target lowered to $42 from $45 at BMO Capital
- Ingevity price target lowered to $50 from $58 at Oppenheimer
- Ingevity Announces Crossett Plant Closure and Restructuring Plans
- Ingevity announces more steps to improve Performance Chemicals profitability
- Ingevity narrows FY24 revenue view to $1.4B-$1.5B from $1.4B-$1.55B
Questions or Comments about the article? Write to editor@tipranks.com